ClinicalTrials.gg
Sign In

Hyperemia clinical trials

The registry lists 98 studies for Hyperemia across more than 10 countries. 44 are recruiting or about to start. 41 of them are mainly about Hyperemia (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09.

Get an email when these change. Save the Hyperemia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
39
Recruiting
28
Not yet recruiting
14
Status unknown
9
Terminated
3
Enrolling by invitation
2

Phase

Phase 3
9
Phase 2
8
Phase 4
4
Phase 1
3
Early Phase 1
2

Where

United States
23
France
17
China
8
Switzerland
6
Canada
5
Turkey
5

Who runs them

Zhuan Zhang (3) · University Hospital, Basel, Switzerland (3) · Kala Pharmaceuticals, Inc. (3) · Georgia State University (3) · Bausch & Lomb Incorporated (3) · University of Iowa (2) · Insel Gruppe AG, University Hospital Bern (2) · Istanbul University - Cerrahpasa (2)

What is being tested here

Drugs under test in Hyperemia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Peanut101
Loteprednol Etabonate023
Brimonidine023
Cabergoline002
Travoprost002
Beet001
Diclofenac001
Latanoprost001
Dipyridamole001
Curcumin001

Coming up

4phase 3 studies under way
21studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 28 Hyperemia studies recruiting now, 17 (61%) set no upper age limit and 7 (25%) stop at 75 or younger. 2 (7%) take children under 18. 2 (7%) are for women only and 0 (0%) for men only; 3 (11%) take healthy volunteers.

Recruiting studies that take each age, of 28
AgeWomenMen
102 (7%)2 (7%)
1824 (86%)24 (86%)
3027 (96%)25 (89%)
4026 (93%)25 (89%)
5027 (96%)26 (93%)
6525 (89%)24 (86%)
7521 (75%)21 (75%)
8521 (75%)21 (75%)

Across all 98 studies, recruiting or not: 19% stop at 75 or younger and 17% at 65; 8% take children; 9% are for women only and 0% for men only; 27% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Hyperemia studies take

Of 28 observational studies under Hyperemia, half reached primary completion within 21 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Observational21 mo16–27 · 28 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting1

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 98. Browse all 98 → or search them.